Volume 305, December 15, 2013 Volume 49, December 15, 2013
Hobbs CA, Blanchard MG, Alijevic O, Tan CD, Kellenberger S, Bencharit S, Cao R, Kesimer M, Walton WG, Henderson AG, Redinbo MR, Stutts MJ, Tarran R. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol 305: L990–L1001, 2013. First published October 11, 2013; doi:10.1152/ajplung.00103.2013 (http://ajplung.physiology.org/content/305/12/L990).
The grant statement was incorrect. The corrected list of grants is shown below.
GRANTS
Funding was provided by the Cystic Fibrosis Foundation Resource Development Program Grant R026 (CFF RDP-R026); National Heart, Lung, and Blood Institute Grants PPG-P01-HL-034322, P01-HL110873, 5 P30-DK-065988-08, R01-HL-103940, and R01-HL-108927; and UNC-Chapel Hill School of Medicine.